Inhibition of the allograft response by donor specific blood transfusion: Association with reduced local th1 cytokines and nitric oxide but enhanced prostaglandin E2 production

Transplantation

Volumn 70, Issue 12, 2000, Pages 1788-1796

  Koga, Shigehiko ^a,b   Luke, Patrick P ^b   Specht, Susan M ^b   Rominski, Barbara ^b   Jaquins Gerstl, Andrea ^b   Hoffman, Rosemary A ^a   Thomson, Angus W ^a,c   Jordan, Mark L ^a,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DILUTION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; ISOGRAFT; LYMPHOCYTE DIFFERENTIATION; MODEL; MOUSE; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROLYMPHOCYTE; PROSTAGLANDIN SYNTHESIS; SPLEEN CELL; TH1 CELL; TH2 CELL;

EID: 0034722907     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200012270-00019     Document Type: Article

References (53)

1. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts
2. The differentiation of cytotoxic cell in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent
3. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity
4. Differential function of major histocompatibility complex antigens in T-lymphocyte activation
5. Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class II MHC antigens
6. Lymphocyte interaction with endothelial cells
7. Lipoxygenase pathway inhibition impairs the allograft response
8. Improvement of kidney graft survival with increased numbers of blood transfusion
9. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients
10. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation
11. Effect of blood transfusions on colonic malignancy recurrence rate
12. Blood transfusion and survival after lung cancer resection
13. Blood transfusion and tumor growth: Evidence from laboratory, animals
14. Effect of blood transfusion and anesthesia on resistance to bacterial peritonitis
15. Induction of antibodies by blood transfusions capable of inhibiting responses in MLC
16. Allograft enhancement by treatment with donor antigens extracted from alloantisera immune complexes
17. Transfer of the beneficial blood transfusion effect on rat renal allograff survival by spleen isografts
18. Suppression of the humans allogeneic response in vitro with primed lymphocytes and suppressive supernates
19. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion
20. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine
21. 2 mediates subset-specific effects on the functional responses of allosensitized T lymphocyte clones
22. Nitric oxide production by moose sponge matrix allograft-infiltrating cells: Comparison with the rat species
23. Nitric oxide synthesis in the in vivo allograft response: A possible regulatory mechanism
24. The effect of prostaglandins and indomethacin on cytotoxic T-Lymphocytes and their precursors
25. Prostaglandins and suppression of the allograft response
26. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
27. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages
28. Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL
29. Generation of cytotoxic T lymphocytes in vitro: I. Response of normal and Immune mouse spleen cells in mixed leukocyte cultures
30. 16N]nitrate in biological fluids
31. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis
32. Differential distribution of antigen-specific helper T cells and cytotoxic T cells after antigenic stimulation in vivo: A functional study using limiting dilution analysis
33. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA41g plus donor-specific transfusion
34. In vivo administration of histocompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors
35. The veto phenomenon in T-cell regulation
36. Characterization of natural killer activity in sponge matrix allografts
37. The effects of donor-specific blood transfusion enhancement of rat renal allografts on host NK cell responses
38. Specific cytotoxic T cells are found in the nonrejected kidneys of blond transfused rats
39. Peripheral tolerance to alloantigen results from altered regulation of the interleukin-2 pathway
40. Heart allografts in murine systems: The differential activation of Th2-1ike effector cells in peripheral tolerance
41. Characterization of the immunosuppressive effect of nitric oxide in graft vs host disease
42. Alloantigen-induced activation of rat splenocytes, is regulated by the oxidative metabolism of L-arginine
43. Macrophages produce nitric oxide at allograft sites
44. The role of cyclic AMP in modulating cytotoxic T lymphocyles: II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents
45. Prostaglandin E2 inhihits production of Th1 lymphokines but not of Th2 lymphokines
46. Cyclic AMP as a mediator of Prostaglandin E-induced suppression of human natural killer cell activity
47. Prostaglandins as endogenous mediators of interleukin 1 production
48. Prostaglandins modulate macrophage la expression
49. Effect of blood transfusion on immune function: III Alterations in macrophage arachidonic acid metabolism
50. Prostaglandin production and suppressor cell induction in transfusion-induced immune suppression
51. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific
52. IL-10 acts on the antigen-presenting cells to inhibit cytokine production by Th 1 cells
53. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans